Cited 101 times in
Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.